Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein
Reactivation of human cytomegalovirus in immunosuppressed transplant patients can cause severe complications. Here, Krishnaet al. show that a fusion toxin protein that specifically binds the viral surface protein US28 can be used to kill latently infected monocytes and their progenitor cells in vitr...
Egile Nagusiak: | , , , , , , , |
---|---|
Formatua: | Artikulua |
Hizkuntza: | English |
Argitaratua: |
Nature Portfolio
2017-02-01
|
Saila: | Nature Communications |
Sarrera elektronikoa: | https://doi.org/10.1038/ncomms14321 |